Clinical Trial Update: Early Hydrocortisone Versus Regular Treatment in Shock in Extremely Preterm Neonates - an Open Randomized Controlled Trial [Phase 4]

View source ↗

Summary

An open randomized Phase 4 trial compares early hydrocortisone treatment to standard care for shock in extremely preterm neonates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Perforation
• Intraventricular Hemorrhage
• Necrotizing Enterocolitis
• Neonatal Sepsis
• Patent Ductus Arteriosus
• Perinatal Asphyxia
• Respiratory Distress Syndrome

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Shock, Preterm Birth Complication | Phase 4 | Status: ACTIVE_NOT_RECRUITING